Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2024.Aug.02

Announcement of the Consolidated Financial Statements for the second quarter of 2024 were approved by the Board of Directors.

2024.Jul.23

Announcement of the Company’s board meeting date to approve 2024Q2 consolidated financial report

2024.Jun.19

Announcement on behalf of OBIGEN that the Company’s Board of Directors resolved to appoint Mr. Frank Chen as Chairperson

2024.Jun.19

Announcement on behalf of OBIGEN of resolution to lift the non-competition restrictions for new directors

2024.Jun.19

Announcement on behalf of OBIGEN of re-election of directors and supervisors at the 2024 Annual General Shareholders’ meeting

2024.Jun.19

Announcement on behalf of OBIGEN of important resolutions of 2024 Annual Shareholders’ meeting and accumulated losses amounting to 50% of paid-in capital

2024.Jun.17

Announcement of 2024 Annual General Shareholders' meeting’s resolution to lift the non-competition restrictions for directors

2024.Jun.17

Announcement of the Company’s important resolutions of the 2024 Annual General Shareholders’ meeting.

2024.Jun.17

OBI-992 TROP2 ADC has been granted by TFDA to proceed to Phase I/II human clinical trial

2024.May.30

OBI has filed the application of a Phase I/II human clinical trial for OBI-992 TROP2 ADC to TFDA

News

Latest News

Events

Latest events